Page 3 - Nasdaq Ormp News Today

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Get Rating) Director Kevin Rakin sold 10,000 shares of the firm’s stock in a transaction on Monday, March 21st. The shares were sold at an average price of $9.41, for a total transaction of $94,100.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can […]

Brokerages predict that Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Get Rating) will report earnings of ($0.19) per share for the current quarter, according to Zacks Investment Research. Two analysts have made estimates for Oramed Pharmaceuticals’ earnings. The highest EPS estimate is ($0.15) and the lowest is ($0.23). Oramed Pharmaceuticals reported earnings of ($0.17) per share during […]

Wall Street analysts forecast that Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Get Rating) will announce $700,000.00 in sales for the current quarter, Zacks reports. Two analysts have provided estimates for Oramed Pharmaceuticals’ earnings. Oramed Pharmaceuticals posted sales of $670,000.00 in the same quarter last year, which suggests a positive year over year growth rate of 4.5%. […]

At the end of the latest market close, Oramed Pharmaceuticals Inc. (ORMP) was valued at $26.50. In that particular session, Stock kicked-off at the price of $26.43 while reaching the peak value of $26.45 and lowest value recorded on the day was $18.92. The stock current value is $18.95.Recently in N